These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 12168799

  • 1. Regulation of human cranial osteoblast phenotype by FGF-2, FGFR-2 and BMP-2 signaling.
    Marie PJ, Debiais F, Haÿ E.
    Histol Histopathol; 2002; 17(3):877-85. PubMed ID: 12168799
    [Abstract] [Full Text] [Related]

  • 2. The Ser252Trp fibroblast growth factor receptor-2 (FGFR-2) mutation induces PKC-independent downregulation of FGFR-2 associated with premature calvaria osteoblast differentiation.
    Lemonnier J, Delannoy P, Hott M, Lomri A, Modrowski D, Marie PJ.
    Exp Cell Res; 2000 Apr 10; 256(1):158-67. PubMed ID: 10739663
    [Abstract] [Full Text] [Related]

  • 3. Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts.
    Mansukhani A, Bellosta P, Sahni M, Basilico C.
    J Cell Biol; 2000 Jun 12; 149(6):1297-308. PubMed ID: 10851026
    [Abstract] [Full Text] [Related]

  • 4. Apoptosis in membranous bone formation: role of fibroblast growth factor and bone morphogenetic protein signaling.
    Fromigue O, Modrowski D, Marie PJ.
    Crit Rev Eukaryot Gene Expr; 2005 Jun 12; 15(1):75-92. PubMed ID: 15831079
    [Abstract] [Full Text] [Related]

  • 5. Effects of FGF-2/-9 in calvarial bone cell cultures: differentiation stage-dependent mitogenic effect, inverse regulation of BMP-2 and noggin, and enhancement of osteogenic potential.
    Fakhry A, Ratisoontorn C, Vedhachalam C, Salhab I, Koyama E, Leboy P, Pacifici M, Kirschner RE, Nah HD.
    Bone; 2005 Feb 12; 36(2):254-66. PubMed ID: 15780951
    [Abstract] [Full Text] [Related]

  • 6. Role of N-cadherin and protein kinase C in osteoblast gene activation induced by the S252W fibroblast growth factor receptor 2 mutation in Apert craniosynostosis.
    Lemonnier J, Haÿ E, Delannoy P, Lomri A, Modrowski D, Caverzasio J, Marie PJ.
    J Bone Miner Res; 2001 May 12; 16(5):832-45. PubMed ID: 11341328
    [Abstract] [Full Text] [Related]

  • 7. The BMP antagonist noggin regulates cranial suture fusion.
    Warren SM, Brunet LJ, Harland RM, Economides AN, Longaker MT.
    Nature; 2003 Apr 10; 422(6932):625-9. PubMed ID: 12687003
    [Abstract] [Full Text] [Related]

  • 8. Increased expression of protein kinase Calpha, interleukin-1alpha, and RhoA guanosine 5'-triphosphatase in osteoblasts expressing the Ser252Trp fibroblast growth factor 2 receptor Apert mutation: identification by analysis of complementary DNA microarray.
    Lomri A, Lemonnier J, Delannoy P, Marie PJ.
    J Bone Miner Res; 2001 Apr 10; 16(4):705-12. PubMed ID: 11315998
    [Abstract] [Full Text] [Related]

  • 9. Increased calvaria cell differentiation and bone matrix formation induced by fibroblast growth factor receptor 2 mutations in Apert syndrome.
    Lomri A, Lemonnier J, Hott M, de Parseval N, Lajeunie E, Munnich A, Renier D, Marie PJ.
    J Clin Invest; 1998 Mar 15; 101(6):1310-7. PubMed ID: 9502772
    [Abstract] [Full Text] [Related]

  • 10. FGF-2 stimulation affects calvarial osteoblast biology: quantitative analysis of nine genes important for cranial suture biology by real-time reverse transcription polymerase chain reaction.
    Mathy JA, Lenton K, Nacamuli RP, Fong KD, Song HM, Fang TD, Yang GP, Longaker MT.
    Plast Reconstr Surg; 2003 Aug 15; 112(2):528-39. PubMed ID: 12900611
    [Abstract] [Full Text] [Related]

  • 11. Integration of FGF and TWIST in calvarial bone and suture development.
    Rice DP, Aberg T, Chan Y, Tang Z, Kettunen PJ, Pakarinen L, Maxson RE, Thesleff I.
    Development; 2000 May 15; 127(9):1845-55. PubMed ID: 10751173
    [Abstract] [Full Text] [Related]

  • 12. Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation.
    Mansukhani A, Ambrosetti D, Holmes G, Cornivelli L, Basilico C.
    J Cell Biol; 2005 Mar 28; 168(7):1065-76. PubMed ID: 15781477
    [Abstract] [Full Text] [Related]

  • 13. Regulatory effects of fibroblast growth factor-8 and tumor necrosis factor-α on osteoblast marker expression induced by bone morphogenetic protein-2.
    Katsuyama T, Otsuka F, Terasaka T, Inagaki K, Takano-Narazaki M, Matsumoto Y, Sada KE, Makino H.
    Peptides; 2015 Nov 28; 73():88-94. PubMed ID: 26409788
    [Abstract] [Full Text] [Related]

  • 14. Fibroblast growth factors lead to increased Msx2 expression and fusion in calvarial sutures.
    Ignelzi MA, Wang W, Young AT.
    J Bone Miner Res; 2003 Apr 28; 18(4):751-9. PubMed ID: 12674336
    [Abstract] [Full Text] [Related]

  • 15. Toward an understanding of nonsyndromic craniosynostosis: altered patterns of TGF-beta receptor and FGF receptor expression induced by intrauterine head constraint.
    Hunenko O, Karmacharya J, Ong G, Kirschner RE.
    Ann Plast Surg; 2001 May 28; 46(5):546-53; discussion 553-4. PubMed ID: 11352430
    [Abstract] [Full Text] [Related]

  • 16. Bone morphogenetic protein is required for fibroblast growth factor 2-dependent later-stage osteoblastic differentiation in cranial suture cells.
    Jiang T, Ge S, Shim YH, Zhang C, Cao D.
    Int J Clin Exp Pathol; 2015 May 28; 8(3):2946-54. PubMed ID: 26045803
    [Abstract] [Full Text] [Related]

  • 17. Extracellular matrix-associated bone morphogenetic proteins are essential for differentiation of murine osteoblastic cells in vitro.
    Suzawa M, Takeuchi Y, Fukumoto S, Kato S, Ueno N, Miyazono K, Matsumoto T, Fujita T.
    Endocrinology; 1999 May 28; 140(5):2125-33. PubMed ID: 10218963
    [Abstract] [Full Text] [Related]

  • 18. Increased osteoblast apoptosis in apert craniosynostosis: role of protein kinase C and interleukin-1.
    Lemonnier J, Haÿ E, Delannoy P, Fromigué O, Lomri A, Modrowski D, Marie PJ.
    Am J Pathol; 2001 May 28; 158(5):1833-42. PubMed ID: 11337381
    [Abstract] [Full Text] [Related]

  • 19. FGF-2 acts through an ERK1/2 intracellular pathway to affect osteoblast differentiation.
    Spector JA, Mathy JA, Warren SM, Nacamuli RP, Song HM, Lenton K, Fong KD, Fang DT, Longaker MT.
    Plast Reconstr Surg; 2005 Mar 28; 115(3):838-52. PubMed ID: 15731686
    [Abstract] [Full Text] [Related]

  • 20. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop.
    Rawadi G, Vayssière B, Dunn F, Baron R, Roman-Roman S.
    J Bone Miner Res; 2003 Oct 28; 18(10):1842-53. PubMed ID: 14584895
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.